Ianotto, J.-C., Chauveau, A., Boyer-Perrard, F., Gyan, E., Laribi, K., Cony-Makhoul, P., Demory, J.-L., de Renzis, B., Dosquet, C., Rey, J., Roy, L., Dupriez, B., Knoops, L., Legros, L., Malou, M., Hutin, P., Ranta, D., Benbrahim, O., Ugo, V., Lippert, E. and Kiladjian, J.-J. (2018) “Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study”, Haematologica. Pavia, Italy, 103(3), pp. 438-446. doi: 10.3324/haematol.2017.181297.